Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

Business Development Tag

Cheshire UK, 29 August 2019 BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator. Spun out from Barts Cancer Institute, Queen Mary University of London, Kinomica Ltd is an...

Nottingham, UK – 02 May 2019   BioCity, a pioneering life science incubator and business collective, today announced investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures. Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to...

BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts...

UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board. Dr Nel Moore has considerable experience in drug development with a track record taking therapeutics to market as former Global Product Vice President at...

Cresset, innovative provider of software and contract research services for small molecule discovery and design, and Elixir Software, provider of real-time workflow tracking applications, have formed an alliance whereby the combination of their technologies will form the basis of a new groundbreaking application, which will radically...

Award-winning MiAlgae considers move into products for human consumption Algae produced from the “co-products” of Scotland’s whisky industry could be used in health products for human consumption, the MediCity, Glasgow based MiAlgae has predicted. Douglas Martin - whose company MiAlgae was crowned Shell LiveWIRE Young Entrepreneur of the year...

XenoGesis has appointed Dr Rachel Hemsley as global head of business development in a drive to support its ambitious growth plans. The Nottingham-based biotechnology company is the UK's largest independent laboratory-based contract research organisation (CRO) specialising in preclinical drug metabolism and pharmacokinetics (DMPK) – enabling it to provide expert...